Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Bernstein Harold. Director active across 1 company, notably Maze Therapeutics, Inc.. In total, 18 reports have been published. Split: 0 buy · 8 sells. Total volume traded: €1.1m. Activity tracked since 29 December 2025. The latest transaction was filed on 13 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bernstein Harold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
16,142 shares@ US$10.42Common StockSEC:0002050172-26-000028:0
16,142 shares@ US$27.6063Common StockSEC:0002050172-26-000028:1
14,609 sharesCommon StockSEC:0002050172-26-000025:0
13,409 sharesCommon StockSEC:0002050172-26-000025:1
1,200 sharesCommon StockSEC:0002050172-26-000025:2
14,853 shares@ US$10.4228.9% of flowCommon StockSEC:0002050172-26-000023:0
13,253 shares@ US$25.574663.2% of flowCommon StockSEC:0002050172-26-000023:1
1,600 shares@ US$26.35767.9% of flowCommon StockSEC:0002050172-26-000023:2
15,000 shares@ US$10.4213.8% of flowCommon StockSEC:0002050172-26-000019:0
11,352 shares@ US$29.241429.3% of flowCommon StockSEC:0002050172-26-000019:1
3,348 shares@ US$30.05858.9% of flowCommon StockSEC:0002050172-26-000019:2
300 shares@ US$31.06670.8% of flowCommon StockSEC:0002050172-26-000019:3
15,000 shares@ US$10.4212.1% of flowCommon StockSEC:0002050172-26-000017:0
30,000 shares@ US$10.4212.4% of flowCommon StockSEC:0002050172-26-000015:0
15,000 shares@ US$10.426.1% of flowCommon StockSEC:0002050172-26-000009:0
25,156 shares@ US$10.4210.3% of flowCommon StockSEC:0002050172-26-000006:0
4,432 shares@ US$10.421.8% of flowCommon StockSEC:0002050172-26-000003:0
45,000 shares@ US$10.4218.3% of flowCommon StockSEC:0002050172-25-000007:0
About Bernstein Harold
Bernstein Harold is a declarant linked to Maze Therapeutics, Inc. on XNAS, where he is President, R&D & CMO. He has 16 filings in total, and in the recent sampled filings, the transactions consist of option exercises and sales for EUR 709399 between 2025-12-31 and 2026-07-02.